Lates News

On September 9th, Lilly announced that it will launch an artificial intelligence and machine learning platform called TuneLab. This platform will open up Lilly's AI drug discovery model trained on its years of research data to biotechnology companies. Lilly stated that the first AI model released this time includes proprietary data acquired with an investment of over $1 billion. (Interface News)